Summary
This prediction ended on 10.01.11 with a price of €15.43. With a performance of -7.39%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| QIAGEN NV | - | - | - | - |
| iShares Core DAX® | -1.347% | 3.576% | 14.229% | 18.356% |
| iShares Nasdaq 100 | 1.169% | 7.020% | 35.388% | 58.850% |
| iShares Nikkei 225® | -0.327% | -0.673% | 8.618% | 6.718% |
| iShares S&P 500 | 0.510% | 4.445% | 28.019% | 49.406% |
According to melinda what are the pros and cons of QIAGEN NV for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread QIAGEN NV diskutieren
Biotechnologie
QIAGEN Marktführer in manuellen und automatisierten Aufreinigung von Nukleinsäuren ACDE Life-Science-Produkten für den Nachweis menschlicher Krankheitserreger
(Laufzeit überschritten)